Johnson & Johnson Repayments of Long-Term Debt
Johnson & Johnson (JNJ) reported Repayments of Long-Term Debt of $1.76 billion for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-02-11
- Johnson & Johnson repayments of long-term debt for the quarter ending 2024-03-31 was $1.00M, a 99.80% decline year-over-year.
- Johnson & Johnson repayments of long-term debt for the quarter ending 2023-12-31 was $1.05B, a 104800.00% increase year-over-year.
- Johnson & Johnson repayments of long-term debt for the quarter ending 2023-10-01 was $1.00M, a 0.00% change year-over-year.
- Johnson & Johnson repayments of long-term debt for the quarter ending 2023-07-02 was $1.00M.
- Johnson & Johnson repayments of long-term debt for fiscal 2025 was $1.76B, a 20.92% increase from fiscal 2024.
- Johnson & Johnson repayments of long-term debt for fiscal 2024 was $1.45B, a 6.32% decline from fiscal 2023.
- Johnson & Johnson repayments of long-term debt for fiscal 2023 was $1.55B, a 27.32% decline from fiscal 2023.
- Johnson & Johnson repayments of long-term debt for fiscal 2023 was $2.13B, a 18.42% increase from fiscal 2022.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2025-12-28 | $1.76B 10-K · filed 2026-02-11 | |||
| 2024-12-29 | $1.45B 10-K · filed 2026-02-11 | |||
| 2024-03-31 | $1.00M 10-Q · filed 2024-05-01 | $1.05B derived: sum of 2 quarters · filed 2026-02-11 | $1.05B derived: sum of 3 quarters · filed 2026-02-11 | $1.05B derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $1.05B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.05B derived: sum of 2 quarters · filed 2026-02-11 | $1.05B derived: sum of 3 quarters · filed 2026-02-11 | $1.55B 10-K · filed 2026-02-11 |
| 2023-10-01 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $2.00M derived: sum of 2 quarters · filed 2023-10-27 | $502.00M 10-Q · filed 2023-10-27 | $503.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-07-02 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $501.00M 10-Q · filed 2023-07-31 | $502.00M derived: sum of 3 quarters · filed 2025-02-13 | $503.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-04-02 | $500.00M 10-Q · filed 2024-05-01 | $501.00M derived: sum of 2 quarters · filed 2025-02-13 | $502.00M derived: sum of 3 quarters · filed 2025-02-13 | $502.00M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-01-01 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $2.00M derived: sum of 2 quarters · filed 2025-02-13 | $2.00M derived: sum of 3 quarters · filed 2025-02-13 | $2.13B 10-K · filed 2025-02-13 |
| 2022-10-02 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $1.00M derived: sum of 2 quarters · filed 2023-10-27 | $2.13B 10-Q · filed 2023-10-27 | $2.48B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-07-03 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | $2.13B 10-Q · filed 2023-07-31 | $2.48B derived: sum of 3 quarters · filed 2024-02-16 | $2.48B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-04-03 | $2.13B 10-Q · filed 2023-04-28 | $2.48B derived: sum of 2 quarters · filed 2024-02-16 | $2.48B derived: sum of 3 quarters · filed 2024-02-16 | $2.93B derived: sum of 4 quarters · filed 2024-02-16 |
| 2022-01-02 | $350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | $351.00M derived: sum of 2 quarters · filed 2024-02-16 | $801.00M derived: sum of 3 quarters · filed 2024-02-16 | $1.80B 10-K · filed 2024-02-16 |
| 2021-10-03 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | $451.00M derived: sum of 2 quarters · filed 2022-10-27 | $1.45B 10-Q · filed 2022-10-27 | $1.95B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-07-04 | $450.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $1.45B 10-Q · filed 2022-07-29 | $1.95B derived: sum of 3 quarters · filed 2023-02-16 | $2.50B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-04-04 | $1.00B 10-Q · filed 2022-04-29 | $1.50B derived: sum of 2 quarters · filed 2023-02-16 | $2.05B derived: sum of 3 quarters · filed 2023-02-16 | $2.05B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-01-03 | $502.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $1.05B derived: sum of 2 quarters · filed 2023-02-16 | $1.05B derived: sum of 3 quarters · filed 2023-02-16 | $1.06B 10-K · filed 2023-02-16 |
| 2020-09-27 | $551.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $551.00M derived: sum of 2 quarters · filed 2021-10-29 | $562.00M 10-Q · filed 2021-10-29 | $2.38B derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-06-28 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $11.00M 10-Q · filed 2021-07-29 | $1.83B derived: sum of 3 quarters · filed 2022-02-17 | $1.83B derived: sum of 4 quarters · filed 2022-02-17 |
| 2020-03-29 | $11.00M 10-Q · filed 2021-04-30 | $1.83B derived: sum of 2 quarters · filed 2022-02-17 | $1.83B derived: sum of 3 quarters · filed 2022-02-17 | $1.83B derived: sum of 4 quarters · filed 2022-02-17 |
| 2019-12-29 | $1.81B derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | $1.82B derived: sum of 2 quarters · filed 2022-02-17 | $1.82B derived: sum of 3 quarters · filed 2022-02-17 | $2.82B 10-K · filed 2022-02-17 |
| 2019-09-29 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-23 | $6.00M derived: sum of 2 quarters · filed 2020-10-23 | $1.01B 10-Q · filed 2020-10-23 | $1.65B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-24 | $1.00B 10-Q · filed 2020-07-24 | $1.65B derived: sum of 3 quarters · filed 2021-02-22 | $2.55B derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $1.00B 10-Q · filed 2020-04-29 | $1.65B derived: sum of 2 quarters · filed 2021-02-22 | $2.55B derived: sum of 3 quarters · filed 2021-02-22 | $2.55B derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-30 | $645.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | $1.55B derived: sum of 2 quarters · filed 2021-02-22 | $1.55B derived: sum of 3 quarters · filed 2021-02-22 | $1.55B 10-K · filed 2021-02-22 |
| 2018-09-30 | $901.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $902.00M derived: sum of 2 quarters · filed 2019-10-28 | $910.00M 10-Q · filed 2019-10-28 | $1.66B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-07-01 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-29 | $9.00M 10-Q · filed 2019-07-29 | $762.00M derived: sum of 3 quarters · filed 2020-02-18 | $1.77B derived: sum of 4 quarters · filed 2020-02-18 |
| 2018-04-01 | $8.00M 10-Q · filed 2019-05-01 | $761.00M derived: sum of 2 quarters · filed 2020-02-18 | $1.77B derived: sum of 3 quarters · filed 2020-02-18 | $1.78B derived: sum of 4 quarters · filed 2020-02-18 |
| 2017-12-31 | $753.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $1.76B derived: sum of 2 quarters · filed 2020-02-18 | $1.77B derived: sum of 3 quarters · filed 2020-02-18 | $1.78B 10-K · filed 2020-02-18 |
| 2017-10-01 | $1.01B derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $1.02B derived: sum of 2 quarters · filed 2018-10-31 | $1.02B 10-Q · filed 2018-10-31 | $2.29B derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-07-02 | $13.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $15.00M 10-Q · filed 2018-08-02 | $1.28B derived: sum of 3 quarters · filed 2019-02-20 | $1.30B derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-04-02 | $2.00M 10-Q · filed 2018-05-01 | $1.27B derived: sum of 2 quarters · filed 2019-02-20 | $1.29B derived: sum of 3 quarters · filed 2019-02-20 | $2.21B derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-01-01 | $1.27B derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.29B derived: sum of 2 quarters · filed 2019-02-20 | $2.21B derived: sum of 3 quarters · filed 2019-02-20 | $2.22B 10-K · filed 2019-02-20 |
| 2016-10-02 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $939.00M derived: sum of 2 quarters · filed 2017-11-02 | $953.00M 10-Q · filed 2017-11-02 | $994.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-07-03 | $922.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $936.00M 10-Q · filed 2017-08-03 | $977.00M derived: sum of 3 quarters · filed 2018-02-21 | $983.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-04-03 | $14.00M 10-Q · filed 2017-05-08 | $55.00M derived: sum of 2 quarters · filed 2018-02-21 | $61.00M derived: sum of 3 quarters · filed 2018-02-21 | $66.00M derived: sum of 4 quarters · filed 2018-02-21 |
| 2016-01-03 | $41.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $47.00M derived: sum of 2 quarters · filed 2018-02-21 | $52.00M derived: sum of 3 quarters · filed 2018-02-21 | $68.00M 10-K · filed 2018-02-21 |
| 2015-09-27 | $6.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $11.00M derived: sum of 2 quarters · filed 2016-11-04 | $27.00M 10-Q · filed 2016-11-04 | $84.00M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-06-28 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $21.00M 10-Q · filed 2016-08-04 | $78.00M derived: sum of 3 quarters · filed 2017-02-27 | $88.00M derived: sum of 4 quarters · filed 2017-02-27 |
| 2015-03-29 | $16.00M 10-Q · filed 2016-05-10 | $73.00M derived: sum of 2 quarters · filed 2017-02-27 | $83.00M derived: sum of 3 quarters · filed 2017-02-27 | $1.84B derived: sum of 4 quarters · filed 2017-02-27 |
| 2014-12-28 | $57.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $67.00M derived: sum of 2 quarters · filed 2017-02-27 | $1.82B derived: sum of 3 quarters · filed 2017-02-27 | $1.84B 10-K · filed 2017-02-27 |
| 2014-09-28 | $10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30 | $1.77B derived: sum of 2 quarters · filed 2015-10-30 | $1.79B 10-Q · filed 2015-10-30 | $1.85B derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-29 | $1.76B derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.78B 10-Q · filed 2015-07-31 | $1.84B derived: sum of 3 quarters · filed 2016-02-24 | $1.87B derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-30 | $21.00M 10-Q · filed 2015-05-01 | $83.00M derived: sum of 2 quarters · filed 2016-02-24 | $110.00M derived: sum of 3 quarters · filed 2016-02-24 | $1.61B derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-29 | $62.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $89.00M derived: sum of 2 quarters · filed 2016-02-24 | $1.59B derived: sum of 3 quarters · filed 2016-02-24 | $1.59B 10-K · filed 2016-02-24 |
| 2013-09-29 | $27.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $1.53B derived: sum of 2 quarters · filed 2014-10-30 | $1.53B 10-Q · filed 2014-10-30 | $1.54B derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $1.50B derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-01 | $1.50B 10-Q · filed 2014-08-01 | $1.51B derived: sum of 3 quarters · filed 2015-02-24 | $2.30B derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $1.00M 10-Q · filed 2014-05-02 | $9.00M derived: sum of 2 quarters · filed 2015-02-24 | $795.00M derived: sum of 3 quarters · filed 2015-02-24 | $775.00M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-30 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $794.00M derived: sum of 2 quarters · filed 2015-02-24 | $774.00M derived: sum of 3 quarters · filed 2015-02-24 | $804.00M 10-K · filed 2015-02-24 |
| 2012-09-30 | $786.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | $766.00M derived: sum of 2 quarters · filed 2013-11-04 | $796.00M 10-Q · filed 2013-11-04 | $800.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-07-01 | -$20.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $10.00M 10-Q · filed 2013-08-01 | $14.00M derived: sum of 3 quarters · filed 2014-02-21 | $21.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-04-01 | $30.00M 10-Q · filed 2013-05-03 | $34.00M derived: sum of 2 quarters · filed 2014-02-21 | $41.00M derived: sum of 3 quarters · filed 2014-02-21 | $43.00M derived: sum of 4 quarters · filed 2014-02-21 |
| 2012-01-01 | $4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-21 | $11.00M derived: sum of 2 quarters · filed 2014-02-21 | $13.00M derived: sum of 3 quarters · filed 2014-02-21 | $16.00M 10-K · filed 2014-02-21 |
| 2011-10-02 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $9.00M derived: sum of 2 quarters · filed 2012-11-09 | $12.00M 10-Q · filed 2012-11-09 | $23.00M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-07-03 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $5.00M 10-Q · filed 2012-08-02 | $16.00M derived: sum of 3 quarters · filed 2013-02-22 | $25.00M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-04-03 | $3.00M 10-Q · filed 2012-05-07 | $14.00M derived: sum of 2 quarters · filed 2013-02-22 | $23.00M derived: sum of 3 quarters · filed 2013-02-22 | $27.00M derived: sum of 4 quarters · filed 2013-02-22 |
| 2011-01-02 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | $20.00M derived: sum of 2 quarters · filed 2013-02-22 | $24.00M derived: sum of 3 quarters · filed 2013-02-22 | $32.00M 10-K · filed 2013-02-22 |
| 2010-10-03 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 | $13.00M derived: sum of 2 quarters · filed 2011-11-08 | $21.00M 10-Q · filed 2011-11-08 | $16.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-07-04 | $4.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-09 | $12.00M 10-Q · filed 2011-08-09 | $7.00M derived: sum of 3 quarters · filed 2012-02-23 | $215.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-04-04 | $8.00M 10-Q · filed 2011-05-10 | $3.00M derived: sum of 2 quarters · filed 2012-02-23 | $211.00M derived: sum of 3 quarters · filed 2012-02-23 | $218.00M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-01-03 | -$5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $203.00M derived: sum of 2 quarters · filed 2012-02-23 | $210.00M derived: sum of 3 quarters · filed 2012-02-23 | $219.00M 10-K · filed 2012-02-23 |
| 2009-09-27 | $208.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-10 | $215.00M derived: sum of 2 quarters · filed 2010-11-10 | $224.00M 10-Q · filed 2010-11-10 | $232.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-06-28 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-11 | $16.00M 10-Q · filed 2010-08-11 | $24.00M derived: sum of 3 quarters · filed 2011-02-25 | $35.00M derived: sum of 4 quarters · filed 2011-02-25 |
| 2009-03-29 | $9.00M 10-Q · filed 2010-05-10 | $17.00M derived: sum of 2 quarters · filed 2011-02-25 | $28.00M derived: sum of 3 quarters · filed 2011-02-25 | |
| 2008-12-28 | $8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-25 | $19.00M derived: sum of 2 quarters · filed 2011-02-25 | $24.00M 10-K · filed 2011-02-25 | |
| 2008-09-28 | $11.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-04 | $16.00M 10-Q · filed 2009-11-04 | ||
| 2008-06-29 | $5.00M 10-Q · filed 2009-08-04 | |||
| 2007-12-30 | $18.00M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |